52 Results

People

  1. Morrow
    Morrow
  2. Stempel
    Stempel
  3. Mamtani
    Mamtani
  4. Zabor
    Zabor
  5. Cody
    Cody
  6. Ho
    Ho
  7. Barrio
    Barrio
  8. Gemignani
    Gemignani
  9. Moo
    Moo
  10. Patil
    Patil

Groups

  1. Surgery (52)
  2. Breast Cancer Disease Management Team (20)
  3. Epidemiology and Biostatistics (14)
  4. Survivorship Research (14)
  5. Biostatistics Service (13)
  6. Department of Medicine (8)
  7. Josie Robertson Surgery Center (8)
  8. Solid Tumor Oncology Division (8)
  9. Breast Medicine Service (7)
  10. Radiation Oncology, Department of (6)
Refine Results
  1. "breast cancer"
  2. "Springer"
  3. "Monica Morrow"
Formats
  1. Journal Article (45)
  2. Editorial (5)
  3. Correspondence (1)
  4. Review (1)
Groups
  1. Surgery (52)
  2. Breast Cancer Disease Management Team (20)
  3. Epidemiology and Biostatistics (14)
  4. Survivorship Research (14)
  5. Biostatistics Service (13)
  6. Department of Medicine (8)

More Groups

People
  1. Monica Morrow (52)
  2. Michelle Stempel (14)
  3. Anita Mamtani (9)
  4. Emily Zabor (8)
  5. Sujata Patil (8)
  6. Mary Gemignani (7)

More People

Years
  1. 2022 (4)
  2. 2021 (6)
  3. 2020 (6)
  4. 2019 (2)
  5. 2018 (2)
  6. 2017 (8)

More Years

Publications
  1. Annals of Surgical Oncology (39)
  2. Breast Cancer Research and Treatment (10)
  3. Clinical and Experimental Metastasis (1)
  4. European Journal of Nuclear Medicine and Molecular Imaging (1)
  5. Journal of Cancer Survivorship (1)
Publishers
  1. Springer (52)

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The effect of age on outcomes after neoadjuvant chemotherapy for breast cancer
    Journal Article

    Verdial, F. C.; Mamtani, A.; Pawloski, K. R.; Sevilimedu, V.; D’Alfonso, T. M.; Zhang, H.; Gemignani, M. L.; Barrio, A. V.; Morrow, M.; Tadros, A. B.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Supervised machine learning model to predict oncotype DX risk category in patients over age 50
    Journal Article

    Pawloski, K. R.; Gonen, M.; Wen, H. Y.; Tadros, A. B.; Thompson, D.; Abbate, K.; Morrow, M.; El-Tamer, M.
    Breast Cancer Research and Treatment (2022)

    Fulltext@MSK | Save
  • ASO author reflections: Heroic mastectomy for chemoresistant disease: A complex decision
    Editorial

    Mamtani, A.; Morrow, M.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Local recurrence is frequent after heroic mastectomy for classically inoperable breast cancers
    Journal Article

    Mamtani, A.; Sevilimedu, V.; Vincent, A.; Morrow, M.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Reply to: “Ketorolac following mastectomy: Is there an increased risk of reoperation?”
    Correspondence

    McCormick, P. J.; Assel, M.; Van Zee, K. J.; Vickers, A. J.; Nelson, J. A.; Morrow, M.; Tokita, H. K.; Simon, B. A.; Twersky, R. S.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • ASO author reflections: Rethinking palpable adenopathy as a marker of high volume axillary nodal disease in hormone receptor positive breast cancer
    Editorial

    Crown, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Management of ipsilateral breast tumor recurrence following breast conservation surgery: A comparative study of re-conservation vs mastectomy
    Journal Article

    Botty Van den Bruele, A.; Chen, I.; Sevilimedu, V.; Le, T.; Morrow, M.; Braunstein, L. Z.; Cody, H. S. 3rd
    Breast Cancer Research and Treatment (2021)

    Fulltext@MSK | Save
  • Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy
    Review

    Pawloski, K. R.; Tadros, A. B.; Sevilimedu, V.; Newman, A.; Gentile, L.; Zabor, E. C.; Morrow, M.; Van Zee, K. J.; Kirstein, L. J.
    Breast Cancer Research and Treatment (2021)

    Fulltext@MSK | Save
  • ASO author reflections: Residual disease in the breast after neoadjuvant chemotherapy does not mandate routine post-mastectomy radiation therapy/regional nodal irradiation
    Editorial

    Crown, A.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Does failure to achieve pathologic complete response with neoadjuvant chemotherapy identify node-negative patients who would benefit from postmastectomy radiation or regional nodal irradiation?
    Journal Article

    Crown, A.; Gonen, M.; Le, T.; Morrow, M.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save